Haplotype Analysis of Identical Factor IX Mutants Using PCR

Summary We have detected the mutations in the factor IX genes from all of the haemophilia B patients registered at Malmo haemophilia centre (45) and are currently examining the entire UK haemophilia B population. From these studies we have found 13 base substitutions which have recurred in 1-6 other, presumably unrelated, patients. In order to determine the minimum number of independent repeats of each mutation we have used PCR to examine the five factor IX polymorphisms forming the most informative combinations and we have characterised the haplotype of each patient. Patients with different haplotypes are assumed to be unrelated and thus to carry independent mutations. All but one of the 13 mutations occur in at least 2 haplotypes thus pinpointing 12 mutational hotspots and mutations that can be clearly considered detrimental. Two of the 13 substitutions occur at non-CpG sites.

[1]  D. Bentley,et al.  Haemophilia B mutations in a complete Swedish population sample: a test of new strategy for the genetic counselling of diseases with high mutational heterogeneity , 1991, British journal of haematology.

[2]  D. Bentley,et al.  The incidence and distribution of CpG----TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspots. , 1990, Nucleic acids research.

[3]  D. Koeberl,et al.  A past mutation at Isoleucine397 is now a common cause of moderate/mild haemophilia B , 1990, British journal of haematology.

[4]  S. Bajaj,et al.  "Founder" effect in different families with haemophilia B mutation , 1990, The Lancet.

[5]  D. Bentley,et al.  The Use of DNA Amplification for Genetic Counselling Related Diagnosis in Haemophilia B , 1989, Thrombosis and Haemostasis.

[6]  D. Bentley,et al.  Direct detection of point mutations by mismatch analysis: application to haemophilia B. , 1989, Nucleic acids research.

[7]  D. Bentley,et al.  Molecular pathology of haemophilia B. , 1989, The EMBO journal.

[8]  D. G. Rees,et al.  DETECTION OF POLYMORPHISMS AT CYTOSINE PHOSPHOGUANADINE DINUCLEOTIDES AND DIAGNOSIS OF HAEMOPHILIA B CARRIERS , 1989, The Lancet.

[9]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[10]  K. Mullis,et al.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.

[11]  G. Brownlee,et al.  DIAGNOSIS OF HAEMOPHILIA B CARRIERS USING INTRAGENIC OLIGONUCLEOTIDE PROBES , 1986, The Lancet.

[12]  A. Thompson,et al.  Use of a BamHI polymorphism in the factor IX gene for the determination of hemophilia B carrier status. , 1986, Blood.

[13]  K. Kurachi,et al.  Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). , 1985, Biochemistry.

[14]  C. Noyes,et al.  Evidence for a prevalent dimorphism in the activation peptide of human coagulation factor IX. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Brownlee,et al.  Carrier detection in haemophilia B using two further intragenic restriction fragment length polymorphisms. , 1984, Nucleic acids research.

[16]  D. Bentley,et al.  A new strategy for carrier and prenatal diagnosis and molecular studies in haemophilia B. , 1991, Current studies in hematology and blood transfusion.

[17]  P. Reitsma,et al.  Haemophilia B: database of point mutations and short additions and deletions. , 1990, Nucleic acids research.